In fact, IGF2BP3 might differentiate normal tissues from cancerous tissues and serve as a prognostic marker for colorectal, hepatocellular, and ovarian clear-cell carcinomas [25–27]. Here, IGF2BP3 is linked to ovarian clear cell cancer.